NIH-funded research NIH-funded research

How COVID-19 vaccines and the microbiome shape immune responses

Official title: Systems biological assessment of innate and adaptive immunity to vaccination

Funded at Stanford University · NIH-11388579 · Data updated 2026-11-12

This project looks at how different COVID-19 vaccines and the gut microbiome change immune responses in adults, including people with serious allergies.

More Vaccination research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startMarch 7, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$2,168,222
NIH project number5U19AI167903-05
Project IDNIH-11388579 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) — especially those with serious allergic diseases or healthy volunteers who can give blood and stool samples and/or have received COVID-19 vaccines — are the ideal candidates.

Less likely to help

Children under 21, people unwilling to provide biological samples, or those with health issues unrelated to immune or allergic conditions are unlikely to benefit directly from this work.

What this research studies

You would be part of work that uses detailed immune testing and microbiome analysis to understand how vaccines trigger protection. The team compares people with serious allergic (atopic) conditions to healthy adults and studies blood and stool samples to map innate and adaptive immune responses. They will analyze samples from a Novavax clinical trial in South Africa and study responses to mRNA vaccines like BNT162b2. Some parts include experiments where the microbiome is altered (for example with antibiotics) to see how that changes vaccine-driven immunity.

Why it matters

Potential benefit: Results could help make COVID-19 vaccines safer and more effective for people with allergies and point to microbiome-based ways to boost vaccine responses.

How similar studies have gone: Previous systems-vaccinology and microbiome studies have linked gut bacteria to vaccine responses, but comparing mRNA and Matrix‑M adjuvanted vaccines in people with serious allergies is a newer application of these methods.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Pulendran, Bali — Stanford University
  • Study coordinator: Pulendran, Bali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.